The 3-item PEG scale is a valid clinical monitoring tool for identifying high-impact chronic pain in adolescents with musculoskeletal pain.

A systematic review and meta-analysis revealed that more than one-fifth of patients with multiple sclerosis experience neuropathic pain.

Combined electronic nudges effectively facilitate serious illness conversations between patients with cancer and their ...

Eptinezumab treatment reduces monthly migraine days and acute medication use in patients with difficult-to-treat episodic or chronic migraine.

Depression and psychological distress serve as significant predictors of persistent low back pain and disability in adult patients.

Researchers conducted a systematic review and meta-analysis evaluating the potential association between endometriosis and migraine.

For-profit hospital status was associated with worse patient and nurse outcomes, partially because of differences in nurse staffing.

Patients with fibromyalgia and multiple disorders of gut-brain interaction experience greater functional impairment and depression.

Acute pain experienced during the acquisition of new motor skills significantly impairs the retention of those skills at 24 hours across age groups.

Medical cannabis seemed to have little to no meaningful effect on quality of sleep, total sleep time, or daytime functioning in adults with insomnia.

Lasmiditan is safe and effective in acute migraine, underscoring the importance of continued development of this medication class.

Pilot trial data indicated structured support interventions attenuate weight gain in adults stopping GLP-1 RA medication.